Global and China Antibody Drug Conjugate Market Insights, Forecast to 2026

Global and China Antibody Drug Conjugate Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Antibody Drug Conjugate Product Introduction
1.2 Market Segments
1.3 Key Antibody Drug Conjugate Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antibody Drug Conjugate Market Size Growth Rate by Type
1.4.2 Adcetris
1.4.3 Kadcyl
1.4.4 Other
1.5 Market by Application
1.5.1 Global Antibody Drug Conjugate Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Pharmaceutical Company
1.5.4 Research Institutions
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antibody Drug Conjugate Market Size, Estimates and Forecasts
2.1.1 Global Antibody Drug Conjugate Revenue 2015-2026
2.1.2 Global Antibody Drug Conjugate Sales 2015-2026
2.2 Global Antibody Drug Conjugate, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Antibody Drug Conjugate Historical Market Size by Region (2015-2020)
2.3.1 Global Antibody Drug Conjugate Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Antibody Drug Conjugate Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Antibody Drug Conjugate Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Antibody Drug Conjugate Sales Forecast by Region (2021-2026)
2.4.2 Global Antibody Drug Conjugate Revenue Forecast by Region (2021-2026)
3 Global Antibody Drug Conjugate Competitor Landscape by Players
3.1 Global Top Antibody Drug Conjugate Sales by Manufacturers
3.1.1 Global Antibody Drug Conjugate Sales by Manufacturers (2015-2020)
3.1.2 Global Antibody Drug Conjugate Sales Market Share by Manufacturers (2015-2020)
3.2 Global Antibody Drug Conjugate Manufacturers by Revenue
3.2.1 Global Antibody Drug Conjugate Revenue by Manufacturers (2015-2020)
3.2.2 Global Antibody Drug Conjugate Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antibody Drug Conjugate Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antibody Drug Conjugate Revenue in 2019
3.2.5 Global Antibody Drug Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Antibody Drug Conjugate Price by Manufacturers
3.4 Global Antibody Drug Conjugate Manufacturing Base Distribution, Product Types
3.4.1 Antibody Drug Conjugate Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibody Drug Conjugate Product Type
3.4.3 Date of International Manufacturers Enter into Antibody Drug Conjugate Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antibody Drug Conjugate Market Size by Type (2015-2020)
4.1.1 Global Antibody Drug Conjugate Sales by Type (2015-2020)
4.1.2 Global Antibody Drug Conjugate Revenue by Type (2015-2020)
4.1.3 Antibody Drug Conjugate Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antibody Drug Conjugate Market Size Forecast by Type (2021-2026)
4.2.1 Global Antibody Drug Conjugate Sales Forecast by Type (2021-2026)
4.2.2 Global Antibody Drug Conjugate Revenue Forecast by Type (2021-2026)
4.2.3 Antibody Drug Conjugate Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antibody Drug Conjugate Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antibody Drug Conjugate Market Size by Application (2015-2020)
5.1.1 Global Antibody Drug Conjugate Sales by Application (2015-2020)
5.1.2 Global Antibody Drug Conjugate Revenue by Application (2015-2020)
5.1.3 Antibody Drug Conjugate Price by Application (2015-2020)
5.2 Antibody Drug Conjugate Market Size Forecast by Application (2021-2026)
5.2.1 Global Antibody Drug Conjugate Sales Forecast by Application (2021-2026)
5.2.2 Global Antibody Drug Conjugate Revenue Forecast by Application (2021-2026)
5.2.3 Global Antibody Drug Conjugate Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Antibody Drug Conjugate Market Size YoY Growth 2015-2026
6.1.1 China Antibody Drug Conjugate Sales YoY Growth 2015-2026
6.1.2 China Antibody Drug Conjugate Revenue YoY Growth 2015-2026
6.1.3 China Antibody Drug Conjugate Market Share in Global Market 2015-2026
6.2 China Antibody Drug Conjugate Market Size by Players (International and Local Players)
6.2.1 China Top Antibody Drug Conjugate Players by Sales (2015-2020)
6.2.2 China Top Antibody Drug Conjugate Players by Revenue (2015-2020)
6.3 China Antibody Drug Conjugate Historic Market Review by Type (2015-2020)
6.3.1 China Antibody Drug Conjugate Sales Market Share by Type (2015-2020)
6.3.2 China Antibody Drug Conjugate Revenue Market Share by Type (2015-2020)
6.3.3 China Antibody Drug Conjugate Price by Type (2015-2020)
6.4 China Antibody Drug Conjugate Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Antibody Drug Conjugate Sales Forecast by Type (2021-2026)
6.4.2 China Antibody Drug Conjugate Revenue Forecast by Type (2021-2026)
6.4.3 China Antibody Drug Conjugate Price Forecast by Type (2021-2026)
6.5 China Antibody Drug Conjugate Historic Market Review by Application (2015-2020)
6.5.1 China Antibody Drug Conjugate Sales Market Share by Application (2015-2020)
6.5.2 China Antibody Drug Conjugate Revenue Market Share by Application (2015-2020)
6.5.3 China Antibody Drug Conjugate Price by Application (2015-2020)
6.6 China Antibody Drug Conjugate Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Antibody Drug Conjugate Sales Forecast by Application (2021-2026)
6.6.2 China Antibody Drug Conjugate Revenue Forecast by Application (2021-2026)
6.6.3 China Antibody Drug Conjugate Price Forecast by Application (2021-2026)
7 North America
7.1 North America Antibody Drug Conjugate Market Size YoY Growth 2015-2026
7.2 North America Antibody Drug Conjugate Market Facts & Figures by Country
7.2.1 North America Antibody Drug Conjugate Sales by Country (2015-2020)
7.2.2 North America Antibody Drug Conjugate Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Antibody Drug Conjugate Market Size YoY Growth 2015-2026
8.2 Europe Antibody Drug Conjugate Market Facts & Figures by Country
8.2.1 Europe Antibody Drug Conjugate Sales by Country
8.2.2 Europe Antibody Drug Conjugate Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Antibody Drug Conjugate Market Size YoY Growth 2015-2026
9.2 Asia Pacific Antibody Drug Conjugate Market Facts & Figures by Country
9.2.1 Asia Pacific Antibody Drug Conjugate Sales by Region (2015-2020)
9.2.2 Asia Pacific Antibody Drug Conjugate Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Antibody Drug Conjugate Market Size YoY Growth 2015-2026
10.2 Latin America Antibody Drug Conjugate Market Facts & Figures by Country
10.2.1 Latin America Antibody Drug Conjugate Sales by Country
10.2.2 Latin America Antibody Drug Conjugate Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Antibody Drug Conjugate Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Antibody Drug Conjugate Market Facts & Figures by Country
11.2.1 Middle East and Africa Antibody Drug Conjugate Sales by Country
11.2.2 Middle East and Africa Antibody Drug Conjugate Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Seattle Genetics/Takeda
12.1.1 Seattle Genetics/Takeda Corporation Information
12.1.2 Seattle Genetics/Takeda Description and Business Overview
12.1.3 Seattle Genetics/Takeda Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Seattle Genetics/Takeda Antibody Drug Conjugate Products Offered
12.1.5 Seattle Genetics/Takeda Recent Development
12.2 Roche
12.2.1 Roche Corporation Information
12.2.2 Roche Description and Business Overview
12.2.3 Roche Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Roche Antibody Drug Conjugate Products Offered
12.2.5 Roche Recent Development
12.3 ImmunoGen
12.3.1 ImmunoGen Corporation Information
12.3.2 ImmunoGen Description and Business Overview
12.3.3 ImmunoGen Sales, Revenue and Gross Margin (2015-2020)
12.3.4 ImmunoGen Antibody Drug Conjugate Products Offered
12.3.5 ImmunoGen Recent Development
12.4 Immunomedics
12.4.1 Immunomedics Corporation Information
12.4.2 Immunomedics Description and Business Overview
12.4.3 Immunomedics Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Immunomedics Antibody Drug Conjugate Products Offered
12.4.5 Immunomedics Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Description and Business Overview
12.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer Antibody Drug Conjugate Products Offered
12.5.5 Pfizer Recent Development
12.6 Celldex Therapeutics
12.6.1 Celldex Therapeutics Corporation Information
12.6.2 Celldex Therapeutics Description and Business Overview
12.6.3 Celldex Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Celldex Therapeutics Antibody Drug Conjugate Products Offered
12.6.5 Celldex Therapeutics Recent Development
12.7 Millennium Pharmaceuticals
12.7.1 Millennium Pharmaceuticals Corporation Information
12.7.2 Millennium Pharmaceuticals Description and Business Overview
12.7.3 Millennium Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Millennium Pharmaceuticals Antibody Drug Conjugate Products Offered
12.7.5 Millennium Pharmaceuticals Recent Development
12.8 Bayer HealthCare
12.8.1 Bayer HealthCare Corporation Information
12.8.2 Bayer HealthCare Description and Business Overview
12.8.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bayer HealthCare Antibody Drug Conjugate Products Offered
12.8.5 Bayer HealthCare Recent Development
12.9 Mersana Therapeutics
12.9.1 Mersana Therapeutics Corporation Information
12.9.2 Mersana Therapeutics Description and Business Overview
12.9.3 Mersana Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Mersana Therapeutics Antibody Drug Conjugate Products Offered
12.9.5 Mersana Therapeutics Recent Development
12.10 Heidelberg Pharma
12.10.1 Heidelberg Pharma Corporation Information
12.10.2 Heidelberg Pharma Description and Business Overview
12.10.3 Heidelberg Pharma Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Heidelberg Pharma Antibody Drug Conjugate Products Offered
12.10.5 Heidelberg Pharma Recent Development
12.11 Seattle Genetics/Takeda
12.11.1 Seattle Genetics/Takeda Corporation Information
12.11.2 Seattle Genetics/Takeda Description and Business Overview
12.11.3 Seattle Genetics/Takeda Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Seattle Genetics/Takeda Antibody Drug Conjugate Products Offered
12.11.5 Seattle Genetics/Takeda Recent Development
12.12 Takeda Pharmaceutical Company Limited
12.12.1 Takeda Pharmaceutical Company Limited Corporation Information
12.12.2 Takeda Pharmaceutical Company Limited Description and Business Overview
12.12.3 Takeda Pharmaceutical Company Limited Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Takeda Pharmaceutical Company Limited Products Offered
12.12.5 Takeda Pharmaceutical Company Limited Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Antibody Drug Conjugate Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antibody Drug Conjugate Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Antibody Drug Conjugate Market Segments
Table 2. Ranking of Global Top Antibody Drug Conjugate Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antibody Drug Conjugate Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Adcetris
Table 5. Major Manufacturers of Kadcyl
Table 6. Major Manufacturers of Other
Table 7. Global Antibody Drug Conjugate Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Antibody Drug Conjugate Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Antibody Drug Conjugate Sales by Regions 2015-2020 (K Units)
Table 10. Global Antibody Drug Conjugate Sales Market Share by Regions (2015-2020)
Table 11. Global Antibody Drug Conjugate Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Antibody Drug Conjugate Sales Forecast by Region (2021-2026) (K Units)
Table 13. Global Antibody Drug Conjugate Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Antibody Drug Conjugate Sales Share by Manufacturers (2015-2020)
Table 15. Global Antibody Drug Conjugate Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Antibody Drug Conjugate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Drug Conjugate as of 2019)
Table 17. Antibody Drug Conjugate Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Antibody Drug Conjugate Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Antibody Drug Conjugate Price (2015-2020) (USD/Unit)
Table 20. Antibody Drug Conjugate Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Antibody Drug Conjugate Product Type
Table 22. Date of International Manufacturers Enter into Antibody Drug Conjugate Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Antibody Drug Conjugate Sales by Type (2015-2020) (K Units)
Table 25. Global Antibody Drug Conjugate Sales Share by Type (2015-2020)
Table 26. Global Antibody Drug Conjugate Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Antibody Drug Conjugate Revenue Share by Type (2015-2020)
Table 28. Antibody Drug Conjugate Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Antibody Drug Conjugate Sales Share by Type (2021-2026)
Table 30. Global Antibody Drug Conjugate Sales by Application (2015-2020) (K Units)
Table 31. Global Antibody Drug Conjugate Sales Share by Application (2015-2020)
Table 32. Global Antibody Drug Conjugate Sales Share by Application (2021-2026)
Table 33. Global Antibody Drug Conjugate Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Antibody Drug Conjugate Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Antibody Drug Conjugate Revenue Market Share Forecast by Application (2021-2026)
Table 36. China Antibody Drug Conjugate Sales (K Units) of Key Companies (2015-2020)
Table 37. China Antibody Drug Conjugate Sales Share by Company (2015-2020)
Table 38. China Antibody Drug Conjugate Revenue (US$ Million) by Company (2015-2020)
Table 39. China Antibody Drug Conjugate Sales (K Units) by Type (2015-2020)
Table 40. China Antibody Drug Conjugate Sales Share by Type (2015-2020)
Table 41. China Antibody Drug Conjugate Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. China Antibody Drug Conjugate Price (K Units) by Type (2015-2020)
Table 43. China Antibody Drug Conjugate Sales (K Units) by Type (2021-2026)
Table 44. China Antibody Drug Conjugate Sales Share by Type (2021-2026)
Table 45. China Antibody Drug Conjugate Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. China Antibody Drug Conjugate Revenue Share by Type (2021-2026)
Table 47. China Antibody Drug Conjugate Price (K Units) by Type (2021-2026)
Table 48. China Antibody Drug Conjugate Sales (K Units) by Application (2015-2020)
Table 49. China Antibody Drug Conjugate Sales Share by Application (2015-2020)
Table 50. China Antibody Drug Conjugate Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. China Antibody Drug Conjugate Sales (K Units) by Application (2021-2026)
Table 52. China Antibody Drug Conjugate Sales Share by Application (2021-2026)
Table 53. China Antibody Drug Conjugate Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. China Antibody Drug Conjugate Revenue Share by Application (2021-2026)
Table 55. North America Antibody Drug Conjugate Sales by Country (2015-2020) (K Units)
Table 56. North America Antibody Drug Conjugate Sales Market Share by Country (2015-2020)
Table 57. North America Antibody Drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Antibody Drug Conjugate Revenue Market Share by Country (2015-2020)
Table 59. Europe Antibody Drug Conjugate Sales by Country (2015-2020) (K Units)
Table 60. Europe Antibody Drug Conjugate Sales Market Share by Country (2015-2020)
Table 61. Europe Antibody Drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Antibody Drug Conjugate Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Antibody Drug Conjugate Sales by Region (2015-2020) (K Units)
Table 64. Asia Pacific Antibody Drug Conjugate Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Antibody Drug Conjugate Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Antibody Drug Conjugate Revenue Market Share by Region (2015-2020)
Table 67. Latin America Antibody Drug Conjugate Sales by Country (2015-2020) (K Units)
Table 68. Latin America Antibody Drug Conjugate Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Antibody Drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Antibody Drug Conjugate Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Antibody Drug Conjugate Sales by Country (2015-2020) (K Units)
Table 72. Middle East and Africa Antibody Drug Conjugate Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Antibody Drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Antibody Drug Conjugate Revenue Market Share by Country (2015-2020)
Table 75. Seattle Genetics/Takeda Corporation Information
Table 76. Seattle Genetics/Takeda Description and Business Overview
Table 77. Seattle Genetics/Takeda Antibody Drug Conjugate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Seattle Genetics/Takeda Antibody Drug Conjugate Product
Table 79. Seattle Genetics/Takeda Recent Development
Table 80. Roche Corporation Information
Table 81. Roche Description and Business Overview
Table 82. Roche Antibody Drug Conjugate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Roche Product
Table 84. Roche Recent Development
Table 85. ImmunoGen Corporation Information
Table 86. ImmunoGen Description and Business Overview
Table 87. ImmunoGen Antibody Drug Conjugate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. ImmunoGen Product
Table 89. ImmunoGen Recent Development
Table 90. Immunomedics Corporation Information
Table 91. Immunomedics Description and Business Overview
Table 92. Immunomedics Antibody Drug Conjugate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Immunomedics Product
Table 94. Immunomedics Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Antibody Drug Conjugate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Pfizer Product
Table 99. Pfizer Recent Development
Table 100. Celldex Therapeutics Corporation Information
Table 101. Celldex Therapeutics Description and Business Overview
Table 102. Celldex Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Celldex Therapeutics Product
Table 104. Celldex Therapeutics Recent Development
Table 105. Millennium Pharmaceuticals Corporation Information
Table 106. Millennium Pharmaceuticals Description and Business Overview
Table 107. Millennium Pharmaceuticals Antibody Drug Conjugate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Millennium Pharmaceuticals Product
Table 109. Millennium Pharmaceuticals Recent Development
Table 110. Bayer HealthCare Corporation Information
Table 111. Bayer HealthCare Description and Business Overview
Table 112. Bayer HealthCare Antibody Drug Conjugate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Bayer HealthCare Product
Table 114. Bayer HealthCare Recent Development
Table 115. Mersana Therapeutics Corporation Information
Table 116. Mersana Therapeutics Description and Business Overview
Table 117. Mersana Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Mersana Therapeutics Product
Table 119. Mersana Therapeutics Recent Development
Table 120. Heidelberg Pharma Corporation Information
Table 121. Heidelberg Pharma Description and Business Overview
Table 122. Heidelberg Pharma Antibody Drug Conjugate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Heidelberg Pharma Product
Table 124. Heidelberg Pharma Recent Development
Table 125. Oxford BioTherapeutics Corporation Information
Table 126. Oxford BioTherapeutics Description and Business Overview
Table 127. Oxford BioTherapeutics Antibody Drug Conjugate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Oxford BioTherapeutics Product
Table 129. Oxford BioTherapeutics Recent Development
Table 130. Takeda Pharmaceutical Company Limited Corporation Information
Table 131. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 132. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Takeda Pharmaceutical Company Limited Product
Table 134. Takeda Pharmaceutical Company Limited Recent Development
Table 135. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 136. Key Challenges
Table 137. Market Risks
Table 138. Main Points Interviewed from Key Antibody Drug Conjugate Players
Table 139. Antibody Drug Conjugate Customers List
Table 140. Antibody Drug Conjugate Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody Drug Conjugate Product Picture
Figure 2. Global Antibody Drug Conjugate Sales Market Share by Type in 2020 & 2026
Figure 3. Adcetris Product Picture
Figure 4. Kadcyl Product Picture
Figure 5. Other Product Picture
Figure 6. Global Antibody Drug Conjugate Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Pharmaceutical Company
Figure 9. Research Institutions
Figure 10. Antibody Drug Conjugate Report Years Considered
Figure 11. Global Antibody Drug Conjugate Market Size 2015-2026 (US$ Million)
Figure 12. Global Antibody Drug Conjugate Sales 2015-2026 (K Units)
Figure 13. Global Antibody Drug Conjugate Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Antibody Drug Conjugate Sales Market Share by Region (2015-2020)
Figure 15. Global Antibody Drug Conjugate Sales Market Share by Region in 2019
Figure 16. Global Antibody Drug Conjugate Revenue Market Share by Region (2015-2020)
Figure 17. Global Antibody Drug Conjugate Revenue Market Share by Region in 2019
Figure 18. Global Antibody Drug Conjugate Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Antibody Drug Conjugate Revenue in 2019
Figure 20. Antibody Drug Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Antibody Drug Conjugate Sales Market Share by Type (2015-2020)
Figure 22. Global Antibody Drug Conjugate Sales Market Share by Type in 2019
Figure 23. Global Antibody Drug Conjugate Revenue Market Share by Type (2015-2020)
Figure 24. Global Antibody Drug Conjugate Revenue Market Share by Type in 2019
Figure 25. Global Antibody Drug Conjugate Market Share by Price Range (2015-2020)
Figure 26. Global Antibody Drug Conjugate Sales Market Share by Application (2015-2020)
Figure 27. Global Antibody Drug Conjugate Sales Market Share by Application in 2019
Figure 28. Global Antibody Drug Conjugate Revenue Market Share by Application (2015-2020)
Figure 29. Global Antibody Drug Conjugate Revenue Market Share by Application in 2019
Figure 30. China Antibody Drug Conjugate Sales Growth Rate 2015-2026 (K Units)
Figure 31. China Antibody Drug Conjugate Revenue Growth Rate 2015-2026 (US$ Million)
Figure 32. China Antibody Drug Conjugate Market Share in Global Market 2015-2026
Figure 33. China 5 and 10 Largest Antibody Drug Conjugate Players Market Share by Revenue in Antibody Drug Conjugate in 2019
Figure 34. China Antibody Drug Conjugate Revenue Share by Type (2015-2020)
Figure 35. China Antibody Drug Conjugate Revenue Growth Rate by Type in 2015 & 2019
Figure 36. China Antibody Drug Conjugate Revenue Share by Application (2015-2020)
Figure 37. China Antibody Drug Conjugate Revenue Growth Rate by Application in 2015 & 2019
Figure 38. North America Antibody Drug Conjugate Sales Growth Rate 2015-2020 (K Units)
Figure 39. North America Antibody Drug Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. North America Antibody Drug Conjugate Sales Market Share by Country in 2019
Figure 41. North America Antibody Drug Conjugate Revenue Market Share by Country in 2019
Figure 42. U.S. Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 43. U.S. Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Canada Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 45. Canada Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Europe Antibody Drug Conjugate Sales Growth Rate 2015-2020 (K Units)
Figure 47. Europe Antibody Drug Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Antibody Drug Conjugate Sales Market Share by Country in 2019
Figure 49. Europe Antibody Drug Conjugate Revenue Market Share by Country in 2019
Figure 50. Germany Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 51. Germany Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 53. France Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 55. U.K. Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 57. Italy Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 59. Russia Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Asia Pacific Antibody Drug Conjugate Sales Growth Rate 2015-2020 (K Units)
Figure 61. Asia Pacific Antibody Drug Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Antibody Drug Conjugate Sales Market Share by Region in 2019
Figure 63. Asia Pacific Antibody Drug Conjugate Revenue Market Share by Region in 2019
Figure 64. China Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 65. China Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 67. Japan Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 69. South Korea Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 71. India Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 73. Australia Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 75. Taiwan Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 77. Indonesia Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 79. Thailand Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 81. Malaysia Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 83. Philippines Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 85. Vietnam Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Latin America Antibody Drug Conjugate Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Antibody Drug Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Antibody Drug Conjugate Sales Market Share by Country in 2019
Figure 89. Latin America Antibody Drug Conjugate Revenue Market Share by Country in 2019
Figure 90. Mexico Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Middle East and Africa Antibody Drug Conjugate Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Antibody Drug Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Antibody Drug Conjugate Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Antibody Drug Conjugate Revenue Market Share by Country in 2019
Figure 100. Turkey Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Antibody Drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Antibody Drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Antibody Drug Conjugate Revenue Growth Rate (201

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs